chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"my daughter's mother had the covid shot and she tends to get sick whenever she gets around him"; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported that a female patient of an unspecified age received bnt162b2, via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Caller wanted to know if Comirnaty is available since she was advised that it is not available anywhere. She wanted to know the differences between Comirnaty and Pfizer biontech covid-19 vaccine since it says on the opening spiel that it is legally distinct. She has a problem with companies mandating/forcing employees to take the covid-19 shot since the available shot from Pfizer is not Comirnaty or the fda-approved vaccine. The caller's verbatim is "my daughter's mother had the covid shot and she tends to get sick whenever she gets around him. We're trying to figure out a detox, to try to get the poison out of his body because she's only 4." The outcome of the event was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Approximately 6 days after, I developed a rash on my thighs, hands, forearms, elbows, upper arms, low back, and some on my lower interior stomach. The rash ranged from welt/hive-like to macule/papule type. The ones on my hands felt more like blisters. I had no anaphylaxis... Mild loose stool. Breathing fine. I still have the rash on my hands, elbows, and upper thighs, but it has started to go down as of today.
patient's mother claims "after every DTap shot Pt receives, he has vomiting and diarrhea about 48 hours later." patient's mother declines bloody vomit or stool, fevers, chills, loss of appetite, etc.
A few minutes after first covid-19 (Pfizer) vaccine, patient developed rash on the arm ( 2 locations, about 3x5 centimeter size). Patient didn't experience any SOB or other symptoms. Patient waited about 30 minutes in the pharmacy to be monitored. Patient's rash started to fade and patient was feeling ok. Patient just came back from 12 hour  shift at hospital so she was tired.  Patient was contacted again on the same day around 5:30 pm to follow up. Patient reported patient is feeling ok.
5-6-19. Awoke with sore/swollen under right arm. Went to school. Complained of feeling cold/shivery at school. Temp 101.7 PM. 5-7-19: Am temp 101.5. Headache, sore/swollen under right arm, fatigue, no appetite. Temp fluctuating between 101.5-103.5. 5-8-19: AM temp 102.3. Headache, sore/swollen under right arm, fatigue, no appetite. Temp fluctuating between 102-103.8 5-9-19: AM temp 102.7. Headache, sore/swollen under right arm, fatigue, no appetite. Awoke with red rash all over body, mostly on trunk.Temp fluctuating between 102-102.8 5-10-19:AM temp 101.7. Headache, sore/swollen under right arm, fatigue, no appetite. Red rash covering entire body. Temp between 101.5-102.8 5-11-19: Am temp 100.5. Headache less intense, sore/swollen right arm, appetite beginning to increase a little. Fatigue continues. Rash still present.PM temp 102. 5-12-19: AM temp 99.9. Slight headache, sore/swollen under right arm. Appetite increasing, Less fatigue. Rash still present. PM temp 99.7 5-13-19: AM temp 99.0 No headache. sore swollen under right arm. Appetite increasing, Fatigue in afternoon, evening. Rash still present, but staring to fade. PM temp 98.7. 5-14-19: AM temp 98.5. No headache. Arm is till swollen, mush less sore. Fatigue in evening. Rash present but fading more. 5-15-19: Temp normal. appetite almost back to normal. Arm swollen, not sore. Fatigue in evening. Rash is fading more. 5-16-19: Temp normal. Appetite almost back to normal. Arm still swollen, not sore. Rash very faint. 5-14-19: AM temp 98.4. No headache 5-12-19
Patient reported that he had the vaccine about two weeks ago and three days after the vaccine he started experiencing a very dry mouth, burning and discomfort. Pt also reported sores in  the corners of his mouth that won't heal. Pt said that is has not gotten any better since the symptoms first appeared. He said that this has never happened before and nothing changed in his medical history except receiving the vaccine.
Presented to ED 48 h after vaccine with chest pain, found to have pericarditis Develop atrial fibrillation, nSTEMI from demand ischemia
At site of injection 7 cm nodule with erythema (target lesion) - mult pox like lesions. Back, arms, legs. (No fever, cough, or coryza). Injection 2 wks ago.
shortness of breath; I was weak; not feeling too good; Heart Beating Too Fast/having a fast beating heart; could hardly make it up stairs because he had an issue walking; Chest pain; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 65-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 as dose 3 (booster), single (Lot number: GJ5342) at the age of 65 years for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (dose 1, single), administration date: 11Mar2021, for COVID-19 immunization; BNT162b2 (dose 2, single), administration date: 01Apr2021, for COVID-19 immunization. The following information was reported: CHEST PAIN (non-serious) with onset 23Sep2022, outcome "not recovered"; HEADACHE (non-serious) with onset 23Sep2022, outcome "not recovered"; HEART RATE INCREASED (non-serious) with onset 23Sep2022, outcome "not recovered", described as "Heart Beating Too Fast/having a fast beating heart"; GAIT DISTURBANCE (non-serious) with onset 23Sep2022, outcome "not recovered", described as "could hardly make it up stairs because he had an issue walking"; DYSPNOEA (non-serious), outcome "unknown", described as "shortness of breath"; ASTHENIA (non-serious), outcome "unknown", described as "I was weak"; MALAISE (non-serious), outcome "unknown", described as "not feeling too good". The events "heart beating too fast/having a fast beating heart", "could hardly make it up stairs because he had an issue walking", "chest pain", "headache", "shortness of breath", "i was weak" and "not feeling too good" required emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: On 22Sep2022, the day after patient received the newest COVID-19 booster, the patient hardly made it up the stairs, he had an issue with walking, his heart was beating too fast, he had chest pain and a headache and that he wanted information on how long these side effects may last. The patient ended up going to the ER. When he got to the ER, patient was told that his heart was beating too fast. It started with the vaccine. He asked how long this will last. The patient was still not feeling too good. By having issues with walking and going upstairs, the patient mean that he was weak and he had shortness of breath. The patient was vaccinated before with the Pfizer vaccine and he never had an issue the following day. After taking this vaccine, the patient can't do much things and he was able to do a lot of things. He was concerned that's why he called.
just a sore arm.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 15Oct2021 11:00 (Lot number: FD0809) at the age of 63 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Arthritis" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (prev dose lot number=EL9265, prev dose administration date=24Feb2021, prev dose administration time=10:00 AM, prev dose dose number=2, prev dose vaccine location=Left arm), administration date: 24Feb2021, when the patient was 63 years old, for COVID-19 Immunization; Bnt162b2 (prev dose lot number=EL1284, prev dose administration date=14Jan2021, prev dose administration time=10:00 AM , prev dose dose number=1, prev dose vaccine location=Left arm), administration date: 14Jan2021, when the patient was 63 years old, for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "just a sore arm.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain in extremity.  Additional information: Patient was not received any other vaccine four weeks prior vaccination and patient did not receive any medication two weeks prior vaccination. Patient not diagnosed with covid-19 prior to vaccination and patient was tested for COVID-19 post vaccination. The patient had no known allergies.  Follow-up attempts are completed. No further information is expected.
no additional adverse events; HCP called to report that a patient was administered a dose of VARIVAX that suffered a TE. Supported TE case number is 02435007. No symptomatic AE reported. No Additional AE/PQC reported.  Names of vaccines involved (including lot/expiration) VARIVAX; This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 24-JUL-2023, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #w034707, expiration date: 01-NOV-2024, administered as prophylaxis (strength, and route of administration were not provided), that suffered a temperature excursion (TE) at a temperature of 35.2 Fahrenheit degrees (14 F up to 46 F) (-10 Celsius degrees up to 8 C) during 4 hours and 40 minutes (Product storage error). No additional symptomatic adverse events were reported.
approx 1 hrs p/inject devel fever 102.5, diaphoresis, chills, achiness; called Hlth Dept & was advised to seek medical care;
The day after the vaccine the patient experienced sores in mouth and a painful, burning sensation on the tongue. She was treated with VALTREX and a compounded mouthwash. At the time of reporting (2/16/19) the sores had resolved, but the tongue was still sore.
DAY AFTER VACCINE PATIENT EXPERIENCED RASH ALL OVER THE BODY. PATIENT SAW DR. THE FOLLOWING DAY AND WAS PRESCRIBED PREDNISONE TO CONTROL RASH
had soreness where the vaccine was given; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (had soreness where the vaccine was given) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced INJECTION SITE PAIN (had soreness where the vaccine was given). On 10-Feb-2021, INJECTION SITE PAIN (had soreness where the vaccine was given) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
5-6 cm red area, blisters closed. Local Rx to Hep A vaccine.
No other AE; ROTATEQ was administered to patients after the excursion occurred; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided.  On 01-NOV-2021, the patient was vaccinated with dose of improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 1 time dose, lot # 1742081, expiration date 18-JUL-2022 (exact dose, route of administration, anatomical location were not reported) for prophylaxis.  Administered dose of vaccine has been stored in the temperature of 35.0 degrees Fahrenheit (°F), 35.1 F, 35.3 F, 35.2 F, 34.9 F for 53 minutes (cumulative). There were no previous temperature excursions reported. No adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2112USA001753: US-009507513-2111USA004488: US-009507513-2112USA001754:
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain in the left arm after 2nd primary dose) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 001B21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Pain in the left arm after 2nd primary dose). At the time of the report, VACCINATION SITE PAIN (Pain in the left arm after 2nd primary dose) outcome was unknown. Patient medical history reported as clear and healthy. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2022-537568, MOD-2022-537572, MOD-2022-537573 (Patient Link).
Patient had no reaction at this time and is in stable condition. He was given an Adult doses of the Pfizer vaccine lot FK9729 due to miscommunication with the parents.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a male patient who received Shingrix for prophylaxis. On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site erythema and injection site warmth. On an unknown date, the outcome of the injection site erythema and injection site warmth were unknown. It was unknown if the reporter considered the injection site erythema and injection site warmth to be related to Shingrix. Additional details were reported as follows: This case was reported by the patient's wife. The age at vaccination was not reported. The patient had redness at the injection site and the injection site was warm to touch.
her fingers turned red; allergic to one of the proteins in the Mrna vaccine; experienced numbness again the day before Easter; face was puffy on right side; eyelid puffy and over-flapped into eyelashes; numbness in the face; Felt foggy; arm sore with in 3 hours of shot; lip started itching; blew up like a balloon; hard & painful; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (arm sore with in 3 hours of shot), LIP PRURITUS (lip started itching), LIP SWELLING (blew up like a balloon), LIP PAIN (hard & painful) and SWELLING FACE (face was puffy on right side) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Food allergy (Allergy to Crab meat), Drug allergy (Allergy to Quinolones: Cipro), Fruit allergy (Allergy to Melons), Fruit allergy (Allergy to Bananas) and Drug allergy (Allergy to Metronidazole).    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm sore with in 3 hours of shot), LIP PRURITUS (lip started itching), LIP SWELLING (blew up like a balloon), LIP PAIN (hard & painful), HYPOAESTHESIA (numbness in the face) and FEELING ABNORMAL (Felt foggy). On 28-Mar-2021, the patient experienced SWELLING FACE (face was puffy on right side) and SWELLING OF EYELID (eyelid puffy and over-flapped into eyelashes). On 03-Apr-2021, the patient experienced HYPOAESTHESIA (experienced numbness again the day before Easter). On an unknown date, the patient experienced ERYTHEMA (her fingers turned red) and ALLERGY TO VACCINE (allergic to one of the proteins in the Mrna vaccine). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 25 milligram; PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE for Adverse event, at an unspecified dose and frequency. On 26-Mar-2021, HYPOAESTHESIA (numbness in the face) and FEELING ABNORMAL (Felt foggy) had resolved. On 27-Mar-2021, LIP PAIN (hard & painful) had resolved. On 28-Mar-2021, LIP SWELLING (blew up like a balloon), SWELLING FACE (face was puffy on right side) and SWELLING OF EYELID (eyelid puffy and over-flapped into eyelashes) had resolved. At the time of the report, PAIN IN EXTREMITY (arm sore with in 3 hours of shot), LIP PRURITUS (lip started itching) and HYPOAESTHESIA (experienced numbness again the day before Easter) had resolved and ERYTHEMA (her fingers turned red) and ALLERGY TO VACCINE (allergic to one of the proteins in the Mrna vaccine) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Follow-up received on 2-jul-2021  updated outcome of the events, added new events and treatment medications.
A few days later I got a few small itchy rashes on my right arm (opposite arm of shot). It looks and feels like poison ivy.  And I didn't touch anything outside so.assume it's from the shot.  I still have it and treatment doesn't help much.
fever; light headedness; This is a spontaneous report from a contactable consumer (patient). An adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced fever and light headedness. Events took place after use of product. The outcome of the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
7 x 10 cm area of erythema (speckled) to l/lateral thigh.  No macules, vesicles, not warm to touch.
COVID vaccine Lot 33025BD, removed by CDPHE from freezer 12-17-21 at 930am, administered to patient on 1-17-2022 after 930am, NO adv rx from pt
During 15 min observation after receiving vaccine, patient reported tingling in lips and diaphoresis. Patient was administered diphenhydramine 50 mg PO while in vaccine clinic, rapid response  was called and patient was transported to the ED. Patient was administered famotidine 40 mg PO and prednisone 50 mg PO and released from ED 5 hrs later.
High pitched crying. Fever. Intense swelling - entire upper leg - hard, swollen and red. Malaise, eyes glazed. Speech regressed for 2 years after this date.
Severe local reaction with redness (10c X 12c) indurate, warm and red with localized swelling on left leg.
Sore Arm for 5days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm right, administration date 03Mar2021 (Lot number: EN6203) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Type 2 diabetes" (unspecified if ongoing), notes: Type 2 diabetes; "Cholesterol" (unspecified if ongoing), notes: Cholesterol; "High blood" (unspecified if ongoing), notes: High blood; "prostate" (unspecified if ongoing), notes: prostate. Concomitant medication(s) included: METFORMIN taken for type 2 diabetes mellitus (ongoing); SIMVASTATIN taken for blood cholesterol abnormal (ongoing); TAMSULOSIN taken for prostate infection (ongoing); LISINOPRIL taken for hypertension (ongoing). The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 03Mar2021, outcome "unknown", described as "Sore Arm for 5days". No follow-up attempts are possible. No further information is expected.
right leg DVT and bilateral pulmonary embolisms. Symptoms of cough, chest pain and dyspnea on exertion started on (about) 4/19/21.  Patient presented to urgent care on 4/26/21 and again on 4/30/21 at which time the diagnosis was made.
Pt had localized reaction to LA 54x65mm induration 52x73mm erythema
felt like she had the flu; headaches; body aches; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (felt like she had the flu), HEADACHE (headaches) and MYALGIA (body aches) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024C21A and 016C21A) for COVID-19 prophylaxis.     Concomitant products included LAMOTRIGINE (LAMICTAL), MIRTAZAPINE, QUETIAPINE, CLONAZEPAM (KLONOPIN), ASPIRIN [ACETYLSALICYLIC ACID], BACLOFEN, FUROSEMIDE (LASIX [FUROSEMIDE]), POTASSIUM CHLORIDE, ATORVASTATIN, PAROXETINE HYDROCHLORIDE (PAXIL [PAROXETINE HYDROCHLORIDE]), CARBIDOPA, LEVODOPA (CARBIDOPA/LEVODOPA), ISOSORBIDE, TRAZODONE and TOPIRAMATE for an unknown indication.   On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jun-2021, the patient experienced INFLUENZA LIKE ILLNESS (felt like she had the flu), HEADACHE (headaches) and MYALGIA (body aches). At the time of the report, INFLUENZA LIKE ILLNESS (felt like she had the flu), HEADACHE (headaches) and MYALGIA (body aches) was resolving.            No medical history information was reported. It was reported that patient had no adverse reactions after dose 1. Patient did not remember which arm she received the vaccine in. Patient felt much better the next day after dose 2 vaccination. No treatment drug details was reported.   This case was linked to MOD-2022-675636 (Patient Link).
On 4/11/08, four (4) Vaccines were administered approximately 11:15 a.m. to outside thighs on both legs. Fever of 101 - 104 began by 6 p.m.  Skin Swelling overnight to @ 1/4 inch high, and circular 4-5 inches wide/long.   Approximately 2 p.m. a small bump, ie., blister-like appeared where shot was given with continual emitting and oozing of pus/blood, and liquid drainage occurred, and continued to grow.  E/R admistered Benadryl and Motrin, and prescribed Bactrim @ 10 p.m. Condition continued to grow until Sun., 4/13/08 9 a.m.  Blister  continues to emit drainage.  Returned to hospital on Mon., 4/14/08 at 2:15 p.m.   Chief of Pediatrics checked out affected right leg and indicated that it looked like the flesh-eating disease, but symptoms were not as severe and ruled it out and he suggested to continue medication; Bactrim for 10 days; Motrin and Benadryl, as needed.
Sharp headache in that feels like it's "inside his brain." Also had unilateral ear and head/face pain on the left side the evening of the vaccine. H/A is recurrent and has not changed. Has treated with ibuprofen , Sudafed, and Nasacort. Was seen by PCM on 4/7 and diagnosed with Neuritis and given Prednisone 30mg taper.